Ticatime 90mg Tablet
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticatime 90mg Tablet
Cardiogard 90mg tablets are antiplatelet agents, a class of medications that inhibit blood clot formation within blood vessels. This action helps prevent strokes and heart attacks in patients with cardiac conditions. Cardiogard 90mg is also indicated for individuals recovering from a recent heart attack or experiencing unstable angina following a cardiac stent placement. Its purpose is to mitigate the risk of recurrent heart attacks, strokes, or stent-related clotting. Concomitant use with aspirin, another antiplatelet medication, is typically prescribed. Cardiogard 90mg can be administered with or without food, consistently at the same time daily, for optimal efficacy. Discontinuing treatment may increase the risk of cardiovascular events. The most frequent adverse effect is increased bleeding tendency; minor cuts may bleed longer than normal, though usually resolving spontaneously. Some patients report mild shortness of breath, which generally subsides with continued use. Persistent bleeding or worsening dyspnea should be reported immediately. Cardiogard 90mg is contraindicated in individuals with active internal bleeding, such as gastric ulcers or intracranial hemorrhage, and those with hepatic impairment. Pre-existing conditions should be disclosed to your physician prior to commencing treatment.
Uses of Ticatime 90mg Tablet
Reducing the risk of cardiac arrest and cerebrovascular accident
Major Benefits of Ticatime 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 90mg Ticatime tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, but consistency in timing is recommended.
Common Side effects of Ticatime 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticatime 90mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticatime 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Ticatime 90mg Tablet works:
Aggrenox 90mg tablets are an antithrombotic agent. Their mechanism of action inhibits platelet aggregation, thus reducing the risk of dangerous thrombus development. This consequently minimizes the likelihood of cardiovascular events such as myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ticatime 90mg Tablets should be approached with care. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Ticatime 90mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticatime 90mg Tablet with breastfeeding are lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Ticatime 90mg Tablets.
KidneySAFE IF PRESCRIBED
Ticatime 90mg tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. Data regarding Ticatime 90mg tablet use in patients undergoing renal dialysis is currently scarce.
LiverCAUTION
Patients with liver impairment should use Ticatime 90mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Ticatime 90mg Tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Ticatime 90mg Tablet :
Should you forget a Ticatime 90mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ticatime 90mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |



